Exploring the development of selective SIRT2 inhibitors as therapeutic agents in B-cell lymphoma and other malignancies through precision medicine approaches.
Discover how CDK8 inhibitors are revolutionizing cancer treatment by targeting the molecular master switch that drives cancer progression.
Exploring the computational discovery of RON receptor tyrosine kinase inhibitors as promising targeted cancer therapies